13th European AIDS Conference/EACS, Belgrade, October 2011

Oral

1 Chronic hepatitis C (HCV) infection and chronic kidney disease (CKD) in HIV-infected patients in the EuroSIDA study. L Peters on behalf of the EuroSIDA study. presentation

2 The incidence of serious non-AIDS defining infections in the EuroSIDA cohort. J Reekie on behalf of the EuroSIDA study. presentation

3 Predictors of hepatitis C viremia in co-infected individuals. D Grint, A Phillips on behalf of the EuroSIDA study. presentation

4 Hepatitis delta in HIV-infected individuals in Europe. V Soriano on behalf of the EuroSIDA study. presentation

5 Non-AIDS defining malignancies (NADM) in the D:A:D study: Time trends and predictors of survival. S Worm for the D:A:D study group. presentation

13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV Rome, July 2011

Oral

Development of a definition for Rapid Progression (RP) of renal disease in HIV-positive persons. L Ryom, DA Kamara, SW Worm, MJ Ross, P Reiss, CA Fux, P Morlat, O Moranne, O Kirk, C Smith and JD Lundgren for the D:A:D study group. presentation

18th Conference on Retroviruses and Opportunistic Infections, Boston, February 2011

Poster Presentations

1 Risk of Cause-specific Deaths over Calendar Time and according to Cumulative Exposure to Combination Antiretroviral Therapy (cART). JD Kowalska, A Mocroft, J Reekie, A Phillips, P Reiss, B Ledergerber, J Gatell, A d'Arminio Monforte, JD Lundgren and O Kirk for the EuroSIDA study group. poster (448 KB)

2 Predictors of Virologic Response to Etravirine-based cART Regimens in a Large European Cohort of HIV-infected Patients. A Cozzi-Lepri, R Paredes, A Phillips, J Kjær, A Lazzarin, J van Lunzen, A Karlsson, M Johnson, and J Lundgren for the EuroSIDA study group. poster (141 KB)

3 HCV Treatment and CD4 Cell Count Decline in HIV/HCV Co-infected Patients: European Cohort Collaboration. C Smit, A d'Arminio, F de Wolf, M Puoti, F Dabis on behalf of the HCV working group of COHERE. poster (99 KB)